Michigan House Passes Kratom Ban, Threatening Industry and Leaving Consumers in Limbo

Michigan House Passes Kratom Ban, Threatening Industry and Leaving Consumers in Limbo

Lansing, MI – April 23, 2026 – The landscape for kratom merchants and consumers in Michigan faces an unprecedented challenge as the state's House of Representatives recently passed House Bill 5537 (HB 5537), a legislative measure aiming for a comprehensive ban on kratom. This development marks a significant shift from previous discussions around regulation and could have far-reaching compliance implications for businesses operating within the state.

What Happened Earlier this month, Michigan lawmakers, led by Representative Cam Cavitt, advanced HB 5537 through the House, largely along party lines. The bill seeks to prohibit the growing, synthesizing, selling, offering for sale, giving, importing, or distributing of kratom or any synthetic variant within Michigan. A violation of this proposed ban would be classified as a criminal misdemeanor, with potential penalties varying based on the specific activity and whether minors are involved. The bill now proceeds to the Michigan Senate for further consideration. This move represents a departure from earlier legislative efforts, such as House Bill 4969 from October 2025, which aimed to establish a regulatory framework similar to the Kratom Consumer Protection Act (KCPA), including age restrictions, licensing, and product testing.

Why It Matters to Kratom Merchants and Consumers Should HB 5537 pass the Senate and be enacted into law, the repercussions for Michigan's kratom industry would be severe. Merchants, including gas stations, smoke shops, vape shops, and online retailers, would be forced to cease all kratom sales and distribution, facing significant economic disruption and potential criminal charges if they fail to comply.

For consumers, particularly those who rely on kratom for pain management or as an alternative to opioids, a ban would eliminate access to a product they perceive as beneficial. Proponents of kratom argue that such a prohibition could inadvertently drive users toward unregulated or more dangerous substances, posing a greater public health risk. Critics of the ban also highlight a crucial distinction, noting that the bill makes no differentiation between natural kratom leaf, which contains minimal amounts of the alkaloid 7-hydroxymitragynine (7-OH), and potentially dangerous synthetic concentrates that contain significantly higher levels.

Compliance Implications If HB 5537 becomes law, the primary compliance directive for all Michigan businesses would be the immediate cessation of all kratom-related activities. The bill does include a narrow provision that would allow for kratom products approved by the Food and Drug Administration (FDA) as a drug, dietary supplement, or food additive to be regulated and legal for that specific use. However, as the FDA has not approved kratom for any medical use and has issued public health warnings, this exception currently offers little practical recourse for the vast majority of kratom products.

What High-Risk Merchants Need to Know About COAs, Lab Testing, and Regulatory Compliance Given the current legislative uncertainty and the inherent "high-risk" classification of kratom by payment processors and regulatory bodies, proactive compliance measures are paramount for merchants. Even in the absence of state-mandated regulations (or in the face of an impending ban), adhering to best practices is crucial:

• Certificates of Analysis (COAs): Merchants should rigorously demand and review COAs from ISO-accredited third-party laboratories for every batch of kratom received. These COAs must clearly detail:
  • Alkaloid Content: Specifically, the levels of mitragynine and 7-hydroxymitragynine (7-OH) to ensure product consistency and safety, especially to guard against overly potent or synthetic variants.
  • Contaminant Screening: Comprehensive testing for heavy metals (e.g., lead, arsenic, cadmium, mercury), pesticides, microbial contaminants (e.g., Salmonella, E. coli), and mold/yeast.
  • Adulterants: Verification that the product is free from dangerous non-kratom substances.
• Independent Lab Testing: Beyond supplier COAs, high-risk merchants should consider periodic independent third-party lab testing to verify the quality, purity, and safety of their products. This demonstrates a commitment to consumer protection and can be vital in navigating a challenging regulatory climate.
• Adherence to KCPA Standards (Even if Not Law): While Michigan's current bill seeks a ban, merchants in unregulated or regulated states should look to the Kratom Consumer Protection Act (KCPA) as a benchmark for responsible practices. This includes implementing age restrictions (e.g., 21+), ensuring clear and accurate product labeling, avoiding unsubstantiated health claims, and marketing products responsibly without appealing to minors.

The situation in Michigan underscores the volatile regulatory environment surrounding kratom. Merchants must remain vigilant, prioritize product safety through rigorous testing, and advocate for sensible regulation over outright prohibition to protect both their businesses and consumer access.